GE HealthCare and RadNet are extending their partnership globally to offer AI-enhanced mammography systems.
Key Details
- 1GE HealthCare and RadNet first partnered in early 2024 to integrate RadNet’s DeepHealth AI breast cancer screening into GEHC mammography devices.
- 2The next phase will see this combined offering distributed internationally, beyond the initial U.S. launch.
- 3The collaboration will now include new AI tools for lesion localization, breast density assessment, and a safeguard review workflow to flag complex cases.
- 4GE HealthCare's platform features a cloud-based multimodality viewer and other workflow enhancements.
- 5RadNet operates over 400 outpatient imaging centers in 10 U.S. states.
Why It Matters
This expansion signifies increased access to advanced, AI-powered breast imaging services for providers worldwide, aiming to facilitate earlier cancer detection and tailored care strategies. The move underscores a growing trend of integrating sophisticated AI into mainstream radiology hardware across global markets.
Source
Radiology Business
Related News
•Radiology Business
New AI Flags Uncertainty in Breast Cancer Imaging Predictions
University of Pittsburgh researchers developed an AI model that quantifies uncertainty in breast cancer diagnostic predictions to enhance trustworthiness.
•Radiology Business
Webinar to Showcase Successful AI Automation in Radiology Workflows
A webinar will provide insights from imaging leaders on expanding and optimizing AI-driven automation in radiology clinical workflows.
•Radiology Business
Everlywell Launches Direct-to-Consumer Mammography AI for Breast Cancer Risk
Everlywell now offers the FDA-authorized Clairity Breast AI tool for patients to assess breast cancer risk from their mammograms.